Published in J Am Soc Nephrol on January 01, 2000
New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol (2009) 3.83
Mediators of inflammation in acute kidney injury. Mediators Inflamm (2010) 2.05
Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol (2002) 1.96
Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol (2008) 1.84
Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest (2002) 1.70
Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 1.64
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol (2008) 1.62
Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol (2008) 1.44
The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol (2008) 1.43
Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol (2008) 1.42
Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol (2007) 1.39
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One (2009) 1.31
Impairment of skin wound healing in beta-1,4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. Am J Pathol (2004) 1.21
Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol (2008) 1.14
Cancer therapy and renal injury. J Clin Invest (2002) 1.14
The contribution of B cells to renal interstitial inflammation. Am J Pathol (2007) 1.14
By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol (2008) 1.11
Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis. Am J Pathol (2004) 1.07
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J Immunol (2008) 1.06
Slit proteins, potential endogenous modulators of inflammation. J Neurovirol (2002) 1.02
Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J Virol (2004) 1.00
Lupus nephritis: an overview of recent findings. Autoimmune Dis (2012) 1.00
Role of T cells in type 2 diabetic nephropathy. Exp Diabetes Res (2011) 0.99
Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem Cell Biol (2009) 0.99
N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research. Hypertension (2009) 0.98
Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. J Clin Immunol (2011) 0.98
CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol (2004) 0.97
Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway. PLoS One (2012) 0.95
Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation. J Am Soc Nephrol (2013) 0.94
Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol (2010) 0.94
CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein. Am J Pathol (2009) 0.92
Vitamin D and chronic kidney disease. Korean J Intern Med (2014) 0.91
Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol (2010) 0.91
Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol (2004) 0.91
Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol (2005) 0.87
Infection and glomerulonephritis. Semin Immunopathol (2007) 0.87
PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. Acta Pharmacol Sin (2008) 0.86
Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86
Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis. Int Immunol (2015) 0.86
Reactive oxygen species mediated calcium oxalate crystal-induced expression of MCP-1 in HK-2 cells. Urol Res (2006) 0.86
Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS One (2012) 0.85
Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring. Adv Wound Care (New Rochelle) (2015) 0.84
Intrapersonal and populational heterogeneity of the chemokine RANTES. Clin Chem (2010) 0.84
Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats. Pediatr Nephrol (2008) 0.83
Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice. Diabetologia (2013) 0.83
Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis. Clin Exp Immunol (2009) 0.83
Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease. Clin Dev Immunol (2013) 0.83
Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes. Clin Exp Nephrol (2013) 0.82
The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells. Mediators Inflamm (2014) 0.82
Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants. Infect Immun (2010) 0.81
Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int (2014) 0.81
Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian J Nephrol (2012) 0.81
Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines. Am J Pathol (2009) 0.81
Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury. Kidney Int Suppl (2011) (2011) 0.81
Deficiency for the chemokine monocyte chemoattractant protein-1 aggravates tubular damage after renal ischemia/reperfusion injury. PLoS One (2015) 0.81
Responses of murine and human macrophages to leptospiral infection: a study using comparative array analysis. PLoS Negl Trop Dis (2013) 0.80
A polymeric nanomedicine diminishes inflammatory events in renal tubular cells. PLoS One (2013) 0.80
Urinary chemokines/cytokines are elevated in patients with urolithiasis. Urol Res (2010) 0.80
RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS. Sci Rep (2016) 0.79
Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol (2012) 0.79
Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney. PLoS One (2013) 0.79
Specific renal parenchymal-derived urinary extracellular vesicles identify age-associated structural changes in living donor kidneys. J Extracell Vesicles (2016) 0.79
Chemokines as potential markers in pediatric renal diseases. Dis Markers (2014) 0.79
The interaction of LFA-1 on mononuclear cells and ICAM-1 on tubular epithelial cells accelerates TGF-β1-induced renal epithelial-mesenchymal transition. PLoS One (2011) 0.79
Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study. J Infect Dis (2015) 0.78
Study of CC chemokine receptor 5 in renal allograft rejection. Indian J Nephrol (2013) 0.78
Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int (2015) 0.78
Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration. Exp Neurol (2015) 0.77
Upregulation of stromal cell-derived factor 1 (SDF-1) is associated with macrophage infiltration in renal ischemia-reperfusion injury. PLoS One (2014) 0.77
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats. J Clin Immunol (2007) 0.77
Evaluation of TGF-β1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction. Arch Med Sci (2013) 0.77
Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety. BMC Immunol (2011) 0.77
Beneficial Effect of Moderate Exercise in Kidney of Rat after Chronic Consumption of Cola Drinks. PLoS One (2016) 0.77
CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population. World J Gastroenterol (2007) 0.76
SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells. PLoS One (2013) 0.76
Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol (2007) 0.76
Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice. Int J Mol Sci (2015) 0.75
Infection-Related Focal Segmental Glomerulosclerosis in Children. Biomed Res Int (2016) 0.75
Biomarkers for kidney involvement in pediatric lupus. Biomark Med (2015) 0.75
Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses. Immunol Cell Biol (2015) 0.75
Angiotensin III increases monocyte chemoattractant protein-1 expression in cultured human proximal tubular epithelial cells. Korean J Intern Med (2015) 0.75
FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines. Mediators Inflamm (2017) 0.75
Early kidney damage induced by subchronic exposure to PM2.5 in rats. Part Fibre Toxicol (2016) 0.75
A Rare Case of Type I RenalTubular Acidosis with Membranous Nephropathy Presenting as Hypokalemic Paralysis. Case Rep Nephrol Urol (2013) 0.75
Arginase-2 Mediates Renal Ischemia/Reperfusion Injury. Am J Physiol Renal Physiol (2017) 0.75
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86
RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet (1994) 3.64
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int (2006) 3.53
Clinical problem-solving. Jumping to the wrong conclusion. N Engl J Med (1998) 3.35
Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol (2001) 3.13
Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med (2000) 3.10
CC chemokine receptor 5 and renal-transplant survival. Lancet (2001) 2.82
Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med (1998) 2.76
Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int (2008) 2.21
Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int (1999) 2.20
Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood (2001) 1.98
Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int (1999) 1.87
Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int (2006) 1.82
Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol (1999) 1.80
Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol (2001) 1.74
The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int (2000) 1.68
Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol (2001) 1.67
A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem (1996) 1.45
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
[Urine diagnosis: test strip analysis and urinary sediment]. Dtsch Med Wochenschr (2001) 1.39
Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum (1999) 1.39
Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis (2001) 1.38
Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem (1979) 1.32
Transcriptional regulation of the interleukin-6 gene in mesangial cells. J Am Soc Nephrol (1999) 1.28
Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J (1999) 1.28
Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men. AIDS (2000) 1.27
Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides. J Immunol (1992) 1.21
Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J (2001) 1.21
Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol (1999) 1.20
The serotonin transporter-imipramine "receptor". J Biol Chem (1983) 1.19
Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem (1979) 1.17
Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry (1978) 1.12
RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant (1996) 1.12
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int (1993) 1.11
Cloning of the xynB gene from Dictyoglomus thermophilum Rt46B.1 and action of the gene product on kraft pulp. Appl Environ Microbiol (1998) 1.09
The hydrogen ion-pumping adenosine triphosphatase of platelet dense granule membrane. Differences from F1F0- and phosphoenzyme-type ATPases. J Biol Chem (1984) 1.08
TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int (1993) 1.08
B cells and tertiary lymphoid organs in renal inflammation. Kidney Int (2007) 1.07
Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras. Mol Cell Biol (1995) 1.07
Altered gene expression and functions of mitochondria in human nephrotic syndrome. FASEB J (1999) 1.05
Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol (1996) 1.05
ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells. Eur J Immunol (2000) 1.05
Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells. FASEB J (2001) 1.04
Hydrogen ion cotransport by the renal brush border glutamate transporter. Biochemistry (1983) 1.04
Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int Suppl (1998) 1.03
A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem (2000) 1.03
CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases. Kidney Int (2007) 1.02
Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol (2000) 1.01
Chemokines and renal disease. Kidney Int (1997) 1.01
Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists. Kidney Int (2006) 1.00
The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins. J Cell Sci (2000) 1.00
Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol (1996) 0.99
Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today (1997) 0.99
Expression of VEGFR3 in glioma endothelium correlates with tumor grade. J Neurooncol (2006) 0.98
Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol (2000) 0.98
MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis (1999) 0.97
RANTES chemokine expression in diseased and normal human tissues. Cytokine (1996) 0.97
Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol (2001) 0.97
Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J (2000) 0.96
Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol (2001) 0.95
Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int (2007) 0.94
Preparation of components of archaeal transcription preinitiation complex. Methods Enzymol (2001) 0.94
The role of chloride ion in platelet serotonin transport. J Biol Chem (1982) 0.94
Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage. Am J Transplant (2007) 0.94
Chemokine-Induced secretion of gelatinase B in primary human monocytes. Biol Chem (2001) 0.93
Patterns of HIV-1 mRNA expression in transgenic mice are tissue-dependent. Virology (1994) 0.93
Monocyte haptotaxis induced by the RANTES chemokine. Curr Biol (1993) 0.93
DNA and protein studies of HLA class II molecules: their relationship to T cell recognition. Immunol Rev (1985) 0.92
Interleukin-1beta induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors. J Neuroimmunol (2000) 0.92
Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol (2001) 0.91
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.90
Hyponatremic encephalopathy after preparation for colonoscopy. Gastrointest Endosc (2001) 0.90
Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol Dial Transplant (2000) 0.89
Analysis of mouse glomerular podocyte mRNA by single-cell reverse transcription-polymerase chain reaction. Kidney Int (1998) 0.89
Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV. J Immunol (2001) 0.89
Hypocalcaemia in HIV infection and AIDS. J Intern Med (1999) 0.88
Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology (Oxford) (2004) 0.88
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing. Oncogene (2006) 0.87
Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS Lett (2001) 0.86
Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int (2006) 0.85
Evidence for two distinct serotonin transport systems in platelets. J Biol Chem (1980) 0.85
Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp Nephrol (2000) 0.85
Sites of recombinant adeno-associated virus integration. Int J Oncol (1998) 0.85
Modulation of Wnt and Hedgehog signaling pathways is linked to retinoic acid-induced amelioration of chronic allograft dysfunction. Am J Transplant (2011) 0.85
Myocarditis and subcutaneous granulomas in a patient with Crohn's disease of the colon. Am J Med (1995) 0.84
[Patient medication counseling--patient counseling about discharge medication]. Med Klin (Munich) (2000) 0.83
Differential activation of CC chemokine receptors by AOP-RANTES. J Biol Chem (2000) 0.83
Determination of DR beta 1 alleles of DR4/Dw subtypes by oligonucleotide probing. Hum Immunol (1987) 0.83
Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation. FASEB J (1999) 0.83
A "minimal signal-stepwise activation" analysis of functional maturation of T lymphocytes. Immunol Rev (1989) 0.82
Lymphatic phenotype of tumour vessels in malignant gliomas. Neuropathol Appl Neurobiol (2008) 0.82